Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT00756665Recruiting

Prostate Active Surveillance Study

Role: collaborator

NCT04794322Recruiting

Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer

Role: collaborator

NCT00843375Recruiting

Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas

Role: collaborator

NCT01511653Completed

Validation of Colon Biomarkers for the Early Detection of Colorectal Adenocarcinoma

Role: collaborator

NCT00844077Completed

Preliminary Longitudinal Validation of Biomarkers Predictive of Barrett's Esophagus

Role: collaborator

All 5 trials loaded